Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes

Catabolism of HDL particles is accelerated in type 2 diabetes, leading to a reduction in plasma residence time, which may be detrimental. Rosuvastatin is the most powerful statin to reduce LDL-cholesterol, but its effects on HDL metabolism in type 2 diabetes remain unknown. We performed a randomized...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Bruno Vergès, Emmanuel Florentin, Sabine Baillot-Rudoni, Jean-Michel Petit, Marie Claude Brindisi, Jean-Paul Pais de Barros, Laurent Lagrost, Philippe Gambert, Laurence Duvillard
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Elsevier 2009-06-01
Serie:	Journal of Lipid Research
Ämnen:	HDL-cholesterol kinetic statin
Länkar:	http://www.sciencedirect.com/science/article/pii/S0022227520308191
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!